PROCEPT BioRobotics Corporation (PRCT) Misses Q3 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.01 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $16.79 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2022 revenue of $72.5 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August